HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jazz Pharmaceuticals plc

http://jazzpharma.com

Latest From Jazz Pharmaceuticals plc

FTC Rebukes Supernus Efforts To Block Sales Of Injector Pen For Use With Generic Apokyn

Agency refutes Supernus’ defense that Sage’s generic drug cartridges are ‘free-riding’ on the supply of the injector pen for its branded product. Company’s alleged exclusionary contract with pen distributor and pressure on specialty pharmacies not to provide the generic involve important antitrust issues, FTC tells court.

Generic Drugs Legal Issues

iPLEDGE REMS: US FDA Advisory Cmte. Supports Relaxing Restrictions But Wants More Data

Panel favors elimination of 19-day lockout after patients who can become pregnant miss the first prescription pickup and continuation of at-home pregnancy tests. Members call for more data from isotretinoin sponsors on why acne patients are not participating in pregnancy registry and on disparities by race and ethnicity.

Advisory Committees Risk Management

Krka Talks Russia, Ukraine, One Year After Conflict Began

Slovenia’s Krka enjoyed a solid year for its dominant Prescription Pharmaceuticals business, with sales climbing by 7% on the back of growth for all six of its geographic business units.

Sales & Earnings Strategy

Cross-Border M&A: 10 Key Trends To Watch In 2023

It will come as no surprise that cross-border M&A is impacted by the world we live in, with geopolitical tensions, rising inflation and interest rates, currency fluctuations, and increased regulatory scrutiny all playing their part in making deals more challenging to execute.

Business Strategies Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Contract Manufacturing Organization
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Alizé Pharma II
    • Azur Pharma Public Limited Company
    • Cavion, Inc.
    • Cavion LLC (Tau Therapeutics LLC
    • Xdynia LLC)
    • Celator Pharmaceuticals, Inc.
    • Gentium S.p.A.
    • GW Pharmaceuticals plc
    • Jazz Pharmaceuticals Ireland Limited
    • Orphan Medical, Inc.
UsernamePublicRestriction

Register